Evaluation of Surgical Outcomes of Endoscopic Third Ventriculostomy

Background: Endoscopic third ventriculostomy (ETV) is an accepted and practiced surgical procedure used to manage hydrocephalus caused by obstruction. The endoscopic third ventriculostomy has minimized mortality and morbidity. Objective: The purpose of this article is to evaluate the surgical results of 90 patients who underwent endoscopic third ventriculostomy. Methodology: A study was conducted at the Department of Neurosurgery in different hospitals in Iraq, hospitals between May 2023 and May 2024 to last for 1 year. The 90 cases included in the study presented obstructive hydrocephalus with obstruction at or distal to the third ventricle in these patients. Endoscopic third ventriculostomy – ETVC was performed in all cases, and the patient's age ranged from 1 to 25 years. All cases were included, evaluated, pre-operatively and post-operatively, and followed in this study. Results: A total of 90 patients were enrolled in this study. Operative time of ETV was 186.58 ± 25.92, anesthesia used was general, postoperative hospital stay was 2-3 days, mortality was 2 cases, stomal malformation was 14 cases, CSF leakage was 2 cases, infection was 3 cases, fontanelle improvement was 78 cases, procedural success was 90%, emotional functioning was 86.63 ± 7.10, psychological functioning was 82.91 ± 3.77. CONCLUSION: Our current study shows that endoscopic third ventriculostomy is considered the most efficient and effective surgical procedure to cure all patients with obstructive hydrocephalus